Interleukin-6 family of cytokines as biochemical markers of osseous changes in the temporomandibular joint disorders

British Journal of Oral and Maxillofacial Surgery

Volumn 42, Issue 3, 2004, Pages 246-250

  Kaneyama, Keiseki ^a   Segami, Natsuki ^a   Sato, Jun ^a   Nishimura, Masaaki ^a   Yoshimura, Hiroshi ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Interleukin 11 (IL 11); Interleukin 17 (IL 17); Interleukin 6 (IL 6); Osseous changes; Synovial fluid; Temporomandibular joint disorder

Indexed keywords

BIOCHEMICAL MARKER; CYTOKINE; INTERLEUKIN 11; INTERLEUKIN 17; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANDIBLE CONDYLE; PATHOGENESIS; STATISTICAL SIGNIFICANCE; SYNOVIAL FLUID LEVEL; TEMPOROMANDIBULAR JOINT DISORDER; VOLUNTEER;

EID: 2442520069     PISSN: 02664356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0266-4356(03)00258-4     Document Type: Article

References (21)

1. Kubota E, Imamura H, Kubota T, Shibata T, Murakami K. Interteukin 1β, and stromelysin (MMP3) activity of synovial fluid as possible markers of osteoarthritis in the temporomandibular joint. J Oral Maxillofac Surg 1997;55:20-7.
2. Shafer DM, Assael L, White LB, Edward FR. Tumor necrosis factor as a biochemical marker of pain and outcome in temporomandibular joints with internal derangements. J Oral Maxillofac Surg 1994;52:786-91.
3. Fu K, Ma XC, Zhang Z, Chen W. Tumor necrosis factor in synovial fluid of patients with temporomandibular disorders. J Oral Maxillofac Surg 1995;53:424-6.
4. Kaneyama K, Segami N, Nishimura M, Suzuki T, Sato J. Importance of proinflammatory cytokines in synovial fluid from 121 joints with temporomandibutar disorders. Br J Oral Maxillofac Surg 2002;40:418-23.
5. Nishimura M, Segami N, Kaneyama K, Suzuki T. Proinflammatory cytokines and arthroscopic findings of patients with internal derangement and osteoarthritis of the temporomandibular joint. Br J Oral Maxillofac Surg 2002;40:68-72.
6. Sandler NA, Buckley MJ, Cillo JE, Thomas WB. Correlation of inflammatory cytokines with arthroscopic findings in patients with temporomandibular joint internal derangements. J Oral Maxillofac Surg 1998;56:534-43.
7. De Bont LGM, Boering G, Liem RSB, Eulderink F, Westesson PL. Osteoarthrtitis and internal derangement of the temporomandibular joint: a light microscopic study. J Oral Maxillofac Surg 1986;44:634-43.
8. Blackwood HJ. Arthritis of the mandibular joint. Br Dent J 1963;115:317-26.
9. Lacey DL, Timms E, Tan HL, et at. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998;93:165-76.
10. Yasuda H, Shima N, Nakagawara N, et al. Osteoctlast differentiation factor is a ligand for osteoprotegerin/osteoclasto-genesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 1998;95:3597-602.
11. Nishimura M, Segami N, Kaneyama K, Suzuki T, Miyamaru M. Relationships between pain-related mediators and both synovitis and joint pain in patients with internal derangements and osteoarthritis of the temporomandibular joint. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;94:328-32.
12. De-Benedetti F, Pignatti P, Gerloni V, et al. Differences in synovial fluid cytokine levels between juvenile and adult rheumatoid arthritis. J Rheumatol 1997;24:1403-9.
13. Trontzas P, Kamper EF, Potaminou A, Kyriazis NC, Kritikos H, Stavridis J. Comparative study of serum and synovial fluid interteukin-11 levels in patients with various arthrides. Clin Biochem 1998;31:673-9.
14. Chevalier S, Fourcin M, Robledo O, Wijdenes J. Interleukin-6 family of cytokines induced activation of different functional sites expressed by gp 130 transducing protein. J Biol Chem 1996;271:14764-72.
15. Hilton DJ, Hilton AA. Cloning of a murine IL-11 receptor alpha-chain; requirement for gp 130 high affinity binding and signal transduction. EMBO J 1994;13:4765-75.
16. Nandurkar HH, Hilton DJ, Nathan P. The human IL-11 receptor requires gp 130 for signaling: demonstration by molecular cloning of receptor. Oncogene 1996;12:585-93.
17. Yin T, Taga T, Tsang MK. Involment of IL-6 signal transducer gp130 in IL-11-mediated signal transduction. J Immunol 1993;151:2555-61.
18. Kurth I, Hosten U, Pflanz S. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes. J Biol Chem 1999;275:36197-203.
19. Kotake S, Udagawa N, Takahashi N, et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 1999;103:1345-52.
20. Jovanovic DV, Martel PJ, Di-Battista JA, et al. Stimulation of 92-kDa gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages: a possible role in rheumatoid arthritis. Arthritis Rheum 2000;43:1134-44.
21. Cai L, Yin JP, Starovasnik MA, et al. Pathways by which interleukin 17 induces articular cartilage breakdown in vitro and in vivo. Cytokine 2001;16:10-21.